Stroke prevention in atrial fibrillation: concepts and controversies.

Curr Cardiol Rev · 2012 · PMC3492813 · PMID 22920480

Europe PMC DOI

hedged sentences

0.0400

closest p · 0.8× alpha

0.0400

boldest claim

The sentences

did not reach statistical significancep=0.04actually significant

Dabigatran 150 mg was found to have an increased rate of myocardial infarction (0.74%) when compared with warfarin (0.53%/year), although this effect did not reach statistical significance (RR 1.38, 95% CI 1–1.91, p=0.04).

also in 111,027 other papers

showed a trendno p-value reported

Apixaban is the only new agent which demonstrated a statistically significant reduction in all-cause mortality compared to warfarin, although dabigatran 150mg BD and rivaroxaban also showed a trend towards reduction in the risk of death.

also in 53,322 other papers

approached significanceno p-value reported

There was a trend towards a reduction in all-cause mortality with dabigatran, which approached significance in the high-dose dabigatran group.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.